Live Breaking News & Updates on Stephenj Farr

Stay updated with breaking news from Stephenj farr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UCB to acquire Zogenix

BRUSSELS and EMERYVILLE, Calif., Jan. 19, 2022 /PRNewswire/ Regulated information – Inside information – UCB (Euronext: UCB) and Zogenix (NASDA. ....

United States , Bruxelles Capitale , Dravetc Dravet , Charl Van Zyl , Tevard Biosciences , Stephenj Farr , Zogenix Inc , Zinc Merger Sub Inc , Committee For Medicinal Products Human Use , National Institute Of Neurological Disorders , Neurology Head Of Europe International , Statement Of Zogenix Inc , Drug Administration , Latham Watkins , Covington Burling , Exchange Commission , Zogenix Press , European Medicines Agency , New Drug Application , Priority Review , Executive Vice President , International Markets , Chief Executive Officer , Zinc Merger Sub , Capital Markets Call , Prescribing Information ,

UCB to acquire Zogenix (1)

And Zogenix (NASDAQ: ZGNX) announced today that the companies have entered into a definitive agreement under. ....

United States , Bruxelles Capitale , Dravetc Dravet , Charl Van Zyl , Tevard Biosciences , Stephenj Farr , Zogenix Inc , Zinc Merger Sub Inc , Committee For Medicinal Products Human Use , National Institute Of Neurological Disorders , Neurology Head Of Europe International , Statement Of Zogenix Inc , Drug Administration , Latham Watkins , Covington Burling , Exchange Commission , Zogenix Press , European Medicines Agency , New Drug Application , Priority Review , Executive Vice President , International Markets , Chief Executive Officer , Zinc Merger Sub , Capital Markets Call , Prescribing Information ,

UCB to acquire Zogenix (3)

- Transaction broadens and builds upon UCB's role as a leader in, and our continued commitment to,. ....

United States , Bruxelles Capitale , Dravetc Dravet , Charl Van Zyl , Tevard Biosciences , Stephenj Farr , Zogenix Inc , Zinc Merger Sub Inc , Committee For Medicinal Products Human Use , National Institute Of Neurological Disorders , Neurology Head Of Europe International , Statement Of Zogenix Inc , Drug Administration , Latham Watkins , Covington Burling , Exchange Commission , Zogenix Press , European Medicines Agency , New Drug Application , Priority Review , Executive Vice President , International Markets , Chief Executive Officer , Zinc Merger Sub , Capital Markets Call , Prescribing Information ,

UCB and Zogenix: UCB to acquire Zogenix

- Transaction broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy, complementing existing medicines and ....

United States , Bruxelles Capitale , Dravetc Dravet , Charl Van Zyl , Tevard Biosciences , Stephenj Farr , Zogenix Inc , Zinc Merger Sub Inc , Committee For Medicinal Products Human Use , National Institute Of Neurological Disorders , Neurology Head Of Europe International , Statement Of Zogenix Inc , Drug Administration , Latham Watkins , Covington Burling , Exchange Commission , Zogenix Press , European Medicines Agency , New Drug Application , Priority Review , Executive Vice President , International Markets , Chief Executive Officer , Zinc Merger Sub , Capital Markets Call , Prescribing Information ,

Belgium Firm to Buy Epilepsy-Focused Biopharma Co. for $1.9B

Shares of Zogenix Inc. rose by 66% after the company reported it entered into an agreement to be acquired by UCB. S.A. of Belgium for $26.00 per share in cash. The offer includes the potential for an additional $2.00 per share if a specific drug approval milestone is met. ....

Bruxelles Capitale , Charl Van Zyl , Stephen Hytha , Stephenj Farr , Neurology Head Of Europe International , Streetwise Reports , European Medicines Agency , Drug Administration , Zogenix Inc , International Markets , Streetwise Report ,